Dashboard
Manage Tickers

ADAP


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-adaptimmune-therapeutics-maintains-4-price-target
HC Wainwright & Co. Reiterates Buy on Adap...
08/13/2024 18:02:05

HC Wainwright & Co. analyst Arthur He reiterates Adaptimmune Therapeutics (NASDAQ:ADAP) with a Buy and maintains $4 pric...

adaptimmune-therapeutics-q2-2024-gaap-eps-004-may-not-be-comparable-to-008-estimate-sales-128231-may-not-be-comparable-to-38483m-estimate
Adaptimmune Therapeutics Q2 2024 GAAP EPS ...
08/12/2024 11:12:23

why-ainos-shares-are-trading-higher-by-around-38-here-are-20-stocks-moving-premarket
Why Ainos Shares Are Trading Higher By Aro...
08/12/2024 10:04:36

the-latest-analyst-ratings-for-adaptimmune-therapeutics
The Latest Analyst Ratings For Adaptimmune...
08/05/2024 15:00:49

hc-wainwright--co-reiterates-buy-on-adaptimmune-therapeutics-maintains-4-price-target
HC Wainwright & Co. Reiterates Buy on Adap...
08/05/2024 09:53:18

HC Wainwright & Co. analyst Arthur He reiterates Adaptimmune Therapeutics (NASDAQ:ADAP) with a Buy and maintains $4 pric...

fda-approves-adaptimmune-therapeutics-engineered-cell-therapy-as-first-for-solid-tumor-and-new-therapy-for-rare-soft-tissue-cancer-in-over-a-decade
FDA Approves Adaptimmune Therapeutics' Eng...
08/02/2024 12:46:46

FDA approves Adaptimmune Therapeutics' Tecelra for unresectable or metastatic synovial sarcoma, a rare cancer near large jo...

trading-halt-halt-status-updated-at-70000-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:00:...
08/02/2024 11:00:04

reported-earlier-adaptimmunes-tecelra-gains-us-fda-accelerated-approval-as-first-engineered-cell-therapy-for-solid-tumors
Reported Earlier, Adaptimmune's TECELRA Ga...
08/02/2024 07:17:24

Approved for advanced MAGE-A4+synovial sarcoma in adults with certain HLA types who have received prior chemotherapy TECELRA...

trading-halt-halted-at-70119-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:01:19 p.m. ET - ...
08/01/2024 23:01:23

hc-wainwright--co-initiates-coverage-on-adaptimmune-therapeutics-with-buy-rating-announces-price-target-of-4
HC Wainwright & Co. Initiates Coverage On ...
07/30/2024 11:07:04

HC Wainwright & Co. analyst Arthur He initiates coverage on Adaptimmune Therapeutics (NASDAQ:ADAP) with a Buy rating and...

why-sentinelone-shares-are-trading-lower-by-16-here-are-other-stocks-moving-in-fridays-mid-day-session
Why SentinelOne Shares Are Trading Lower B...
05/31/2024 17:17:02

why-adaptimmune-therapeutics-adap-stock-is-moving
Why Adaptimmune Therapeutics (ADAP) Stock ...
05/31/2024 14:28:47

Adaptimmune Therapeutics shares are trading higher by 15.8% during Friday's session. The company and Galapagos entered a cl...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
05/31/2024 12:06:22

why-zscaler-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket
Why Zscaler Shares Are Trading Higher By A...
05/31/2024 11:44:15

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
05/30/2024 20:31:17

Core News & Articles
Galapagos And Adaptimmune Enter Clinical C...
05/30/2024 20:02:10

Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next gener...

scotiabank-initiates-coverage-on-adaptimmune-therapeutics-with-sector-outperform-rating-announces-price-target-of-315
Scotiabank Initiates Coverage On Adaptimmu...
05/30/2024 14:35:49

Scotiabank analyst George Farmer initiates coverage on Adaptimmune Therapeutics (NASDAQ:ADAP) with a Sector Outperform ratin...

mizuho-maintains-buy-on-adaptimmune-therapeutics-lowers-price-target-to-3
Mizuho Maintains Buy on Adaptimmune Therap...
05/17/2024 11:31:55

Mizuho analyst Graig Suvannavejh maintains Adaptimmune Therapeutics (NASDAQ:ADAP) with a Buy and lowers the price target fro...

adaptimmune-therapeutics-q1-2024-gaap-eps-003-beats-009-estimate-sales-5678m-miss-10733m-estimate
Adaptimmune Therapeutics Q1 2024 GAAP EPS ...
05/15/2024 12:00:07

Adaptimmune Therapeutics (NASDAQ:ADAP) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
04/19/2024 20:31:47

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION